Hambleton Catherine, Buell Joseph, Saggi Bob, Balart Luis, Shores Nathan J, Kandil Emad
Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Department of Gastroenterology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Ann Otol Rhinol Laryngol. 2013 Nov;122(11):679-82. doi: 10.1177/000348941312201103.
Thyroid storm is a presentation of severe thyrotoxicosis that has a mortality rate of up to 20% to 30%. Fulminant hepatic failure (FHF) entails encephalopathy with severe coagulopathy in the setting of liver disease. It carries a high mortality rate, with an approximately 60% rate of overall survival for patients who undergo orthotopic liver transplantation (OLT). Fulminant hepatic failure is a rare but serious complication of thyroid storm. There have been only 6 previously reported cases of FHF with thyroid storm.
We present a patient from our institution with thyroid storm and FHF. A literature review was performed to analyze the outcomes of the 6 additional cases of concomitant thyroid storm and FHF.
Our patient underwent thyroidectomy followed by OLT. Her serum levels of thyroid-stimulating hormone, triiodothyronine, thyroxine, and transaminase normalized, and she was ready for discharge within 10 days of surgery. She has survived without complication. There is a 40% mortality rate for the reported patients treated medically with these conditions. Of the 7 total cases of reported FHF and thyroid storm, 2 patients died. Only 2 of the 7 patients underwent thyroidectomy and OLT--both at our institution. Both patients survived without complications.
Thyroid storm and FHF each independently carry high mortality rates, and managing patients with both conditions simultaneously is an extraordinary challenge. These cases should compel clinicians to investigate liver function in hyperthyroid patients and to be wary of its rapid decline in patients who present in thyroid storm with symptoms of liver dysfunction. Patients with rapidly progressing thyroid storm and FHF should be considered for total thyroidectomy and OLT.
甲状腺危象是严重甲状腺毒症的一种表现形式,死亡率高达20%至30%。暴发性肝衰竭(FHF)是指在肝病背景下伴有严重凝血病的肝性脑病。其死亡率很高,接受原位肝移植(OLT)的患者总体生存率约为60%。暴发性肝衰竭是甲状腺危象罕见但严重的并发症。此前仅有6例甲状腺危象合并暴发性肝衰竭的病例报道。
我们报告了本院一名患有甲状腺危象和暴发性肝衰竭的患者。进行文献综述以分析另外6例甲状腺危象合并暴发性肝衰竭病例的治疗结果。
我们的患者先接受了甲状腺切除术,随后进行了原位肝移植。她的促甲状腺激素、三碘甲状腺原氨酸、甲状腺素和转氨酶血清水平恢复正常,术后10天内即可出院。她存活下来且无并发症。据报道,接受药物治疗的这些患者死亡率为40%。在总共7例暴发性肝衰竭合并甲状腺危象的报道病例中,有2例死亡。7例患者中只有2例接受了甲状腺切除术和原位肝移植,均在本院。这两名患者均存活且无并发症。
甲状腺危象和暴发性肝衰竭各自的死亡率都很高,同时治疗这两种病症的患者是一项巨大挑战。这些病例应促使临床医生对甲状腺功能亢进患者的肝功能进行检查,并警惕甲状腺危象伴有肝功能障碍症状的患者肝功能的迅速下降。对于甲状腺危象和暴发性肝衰竭进展迅速的患者,应考虑行全甲状腺切除术和原位肝移植。